Results 81 to 90 of about 2,211 (199)

Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review

Clinical Pharmacology &Therapeutics, Volume 120, Issue 1, Page 94-108, July 2026.
Interest in ayahuasca and its main component, N,N‐Dimethyltryptamine (DMT), has currently moved from historical and experimental use into modern clinical development. Yet, current evidence is fragmented, and systematic mapping of trial methods and design choices remains limited.
Tijana Stojanović, Kent W. Nilsson, Robert Fredriksson, Helgi B. Schiöth, Thiago C. Moulin   +4 more
wiley   +1 more source

Personalised Perception: The Effect of Personality on the Sensory Effects of Psychedelics

Drug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction Psychedelics induce a wide range of sensory distortions and hallucinations (henceforth ‘distortions’). Yet, little is known about factors that influence the occurrence of certain distortions. Extra‐pharmacological variables including personality traits have been found to correlate with the occurrence of different subjective ...
Alexander Boardman, Jai Whelan, Ryan D. Ward   +2 more
wiley   +1 more source

The Effects of LSD and Psilocin on Anxiety-Related Behaviours in Zebrafish

, 2017
Recently there has been a surge in interest in the research of hallucinogens, particularly serotonergic hallucinogens. While some preliminary research has shown some promising applications in the treatment of anxiety, these compounds are still poorly ...
Walley, Anne
core  

Taxonomic Identification of Hallucinogenic Mushrooms Seized on the Illegal Market Using a DNA-Based Approach and LC/MS-MS Determination of Psilocybin and Psilocin [PDF]

, 2015
The taxonomic identification of mushrooms suspected to contain hallucinogenic active principles was carried out using a DNA-based approach, thus highlighting the usefulness of this approach in the forensic identification of illegal samples also when ...
G. Roda, G.L. Visconti, C. Rusconi, C. Ceravolo, L. Dell’Acqua, E. Casagni, S. Arioli, D. Mora, S. Arnoldi, V. Gambaro, L. Tamborini, F. Farè   +11 more
core   +1 more source

Screening and Confirmation of Psilocin, Mitragynine, Phencyclidine, Ketamine, and Ketamine Metabolites by Liquid Chromatography Tandem Mass Spectrometry.

Journal of Analytical Toxicology
A safe and productive workplace requires a sober workforce, free from substances that impair judgment and concentration. Although drug monitoring programs already exist, the scope and loopholes of standard workplace testing panels are well-known ...
M. Wood, Glenna J. Brown, Erin L Karschner, Joshua Z Seither, Jordan T Brown, Jessica L Knittel, J. Walterscheid   +6 more
semanticscholar   +1 more source

A Missing Voice? Peer Support Workers’ Perceptions of Psychedelic‐Assisted Therapy in Australia: A Cross‐Sectional Survey

Brain and Behavior, Volume 16, Issue 6, June 2026.
Despite their capacity to bridge providers and clients, peer support workers remain largely absent from Australia's emerging psychedelic‐assisted therapy (PAT) landscape. This study identifies a broadly supportive and optimistic PSW workforce, while highlighting the need for tailored education pathways and structured integration models to enable ...
Aloysius Amos Lau, Shalini Arunogiri, Boen Raner‐Galutera, Siegfried Lichtwark, Sarah J. Catchlove   +4 more
wiley   +1 more source

Unveiling the Power of Deuterium in Drug Discovery: A Comprehensive Overview

MedComm, Volume 7, Issue 6, June 2026.
The role of deuterium replacement in drug discovery, its progress, opportunities, and challenges. ABSTRACT Deuterium, the heavy isotope of hydrogen, has unfolded as a cornerstone in modern drug discovery due to its potential to influence metabolic stability and pharmacokinetic behavior.
Mukta Lele, Ajit Manchare, Swapnali Parit, Amol D. Gholap, Krishna Jadhav, Navnath Hatvate, Keshav Raj Paudel, Satish Rojekar   +7 more
wiley   +1 more source

The psychedelic psilocin fosters neuroplasticity in iPSC-derived human cortical neurons [PDF]

Psychedelics have the fascinating potential to induce altered states of consciousness. First promising research for their therapeutical application stopped in the early 70’s when psychedelics were criminalized.
Schmidt, Malin
core   +1 more source

Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled Settings

International Journal of Methods in Psychiatric Research, Volume 35, Issue 2, June 2026.
ABSTRACT Objectives For English, the validated part of Psychedelic Experience Scale (PES48) is a four‐factor structure called the Mystical Experience Questionnaire (MEQ30). The other validated part of the PES48 consists of four more factors: two more mystical factors (paradoxicality and connectedness, which together with the MEQ30 form the MEQ40), and ...
Kurt Stocker, Matthias Hartmann, Frederick S. Barrett, William A. Richards, Nathan D. Sepeda, Laura Ley, Anna M. Becker, Friederike Holze, Matthias E. Liechti   +8 more
wiley   +1 more source

Investigation into the temporal stability of aqueous standard solutions of psilocin and psilocybin using high performance liquid chromatography

, 2006
This paper reports an investigation into the temporal stability of aqueous solutions of psilocin and psilocybin reference drug standards over a period of fourteen days.
Anastos, N., Pfeffer, F., Barnett, N., Lewis, Simon   +3 more
core   +1 more source